Helius Medical Technologies (NASDAQ:HSDT) Issues Earnings Results, Misses Estimates By $0.14 EPS

Helius Medical Technologies (NASDAQ:HSDT) issued its quarterly earnings data on Monday. The company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.50) by ($0.14), Zacks reports. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. The company had revenue of $0.18 million during the quarter. During the same period last year, the firm posted ($3.00) earnings per share.

Helius Medical Technologies Stock Down 5.2 %

Shares of NASDAQ:HSDT traded down $0.04 during trading on Wednesday, hitting $0.72. 29,867 shares of the company were exchanged, compared to its average volume of 326,762. Helius Medical Technologies has a 1-year low of $0.65 and a 1-year high of $13.43. The company has a market capitalization of $2.12 million, a P/E ratio of -0.06 and a beta of 1.60. The business’s 50 day moving average is $0.91 and its 200-day moving average is $3.33.

Helius Medical Technologies Company Profile

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.